Radiotherapy for Atypical Teratoid/=Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
Andrew RoehrigDaniel J IndelicatoArnold C PaulinoRalph ErmoianWilliam HartsellJohn PerentesisChristine Hill-KayserJae Y LeeNadia N LaackVictor MangonaIain MacEwanBree R EatonSara GallottoBenjamin V M BajajPaul D AridgidesTorunn I YockPublished in: Journal of neuro-oncology (2023)
The PPCR ATRT cohort found no differences in outcomes according to receipt of either higher primary dose or larger RT field (CSI). However, most patients were M0 and received focal RT. A lower primary dose (50.4 Gy), regardless of patient age, is appealing for further study as part of multi-modality therapy.